Skip to content
10-Q

Quarterly Report

Turnstone Biologics Corp.

0000950170-24-058818

← back to feed
Filed
May 13, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Short Term Investments Q1 2024 · Mar 31, 2024 $63.41M
Short Term Investments Q1 2024 · Dec 31, 2023 $76.98M
Cash And Equivalents Q1 2024 · Mar 31, 2024 $14.43M
Cash And Equivalents Q1 2024 · Dec 31, 2023 $17.8M
Current Liabilities Q1 2024 · Mar 31, 2024 $12.65M
Current Liabilities Q1 2024 · Dec 31, 2023 $11.97M
Total Liabilities Q1 2024 · Mar 31, 2024 $14.38M
Total Liabilities Q1 2024 · Dec 31, 2023 $14.15M
Current Assets Q1 2024 · Mar 31, 2024 $84.98M
Current Assets Q1 2024 · Dec 31, 2023 $102.55M
Total Assets Q1 2024 · Mar 31, 2024 $94.39M
Total Assets Q1 2024 · Dec 31, 2023 $112.82M
Shares Diluted Q1 2024 · Mar 31, 2023 2.79M sh
Capex Q1 2024 · Mar 31, 2023 $880K
Operating Cash Flow Q1 2024 · Mar 31, 2023 −$17.17M
Stockholders Equity Q1 2024 · Mar 31, 2023 −$100.22M
Stockholders Equity Q1 2024 · Dec 31, 2022 −$101.47M
Sga Expense Q1 2024 · Mar 31, 2023 $4.03M
Rd Expense Q1 2024 · Mar 31, 2023 $15.67M
Net Income Q1 2024 · Mar 31, 2023 $68K
Operating Income Q1 2024 · Mar 31, 2023 −$394K
Revenue Q1 2024 · Mar 31, 2023 $19.31M